Events
Median
TTP
P-value
Lapatinib +
capecitabine (n=198)
82 (41%)
6.2 months
(27.1 weeks)
0.0001
Capecitabine (n=201)
102
(51%)
4.3 months
(18.6 weeks)
Lapatinib + capecitabina
EGF100151: Time to progression
•
CI = confidence interval; TTP = time to progression.
•
Geyer, NEJM 2006
.
100
90
80
70
60
50
40
30
20
10
0
0
10
20
30
40
50
60
70
80
90
Cumulative progression-free
survival (%)
Time since randomisation (weeks)
Hazard ratio: 0.57 (95% CI: 0.43, 0.77
